EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 276 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,030,000 | +31.0% | 9,968 | +0.2% | 0.02% | +18.8% |
| Q2 2020 | $786,000 | -54.4% | 9,950 | -65.8% | 0.02% | -71.4% |
| Q4 2018 | $1,723,000 | -7.2% | 29,062 | +3.1% | 0.06% | +5.7% |
| Q3 2018 | $1,856,000 | +29.2% | 28,191 | -0.9% | 0.05% | +20.5% |
| Q2 2018 | $1,436,000 | -0.1% | 28,440 | +4.2% | 0.04% | -4.3% |
| Q1 2018 | $1,437,000 | +103.3% | 27,299 | +8.6% | 0.05% | +24.3% |
| Q2 2016 | $707,000 | -26.6% | 25,137 | -5.2% | 0.04% | -32.7% |
| Q1 2016 | $963,000 | -8.7% | 26,505 | +0.5% | 0.06% | -11.3% |
| Q4 2015 | $1,055,000 | +46.7% | 26,364 | +4.5% | 0.06% | +40.9% |
| Q3 2015 | $719,000 | -2.3% | 25,229 | +12.9% | 0.04% | +2.3% |
| Q2 2015 | $736,000 | +20.5% | 22,341 | +5.2% | 0.04% | +19.4% |
| Q1 2015 | $611,000 | +13.4% | 21,228 | +7.3% | 0.04% | +9.1% |
| Q4 2014 | $539,000 | +54.4% | 19,779 | +20.7% | 0.03% | +43.5% |
| Q3 2014 | $349,000 | – | 16,383 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,810,519 | $52,071,000 | 4.06% |
| Avoro Capital Advisors LLC | 330,635 | $9,509,000 | 3.65% |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC | 766,424 | $22,043,000 | 1.32% |
| GREAT POINT PARTNERS LLC | 102,791 | $2,956,000 | 1.30% |
| Matarin Capital Management, LLC | 75,380 | $2,167,929,000 | 0.66% |
| GLOBEFLEX CAPITAL L P | 89,151 | $2,564,000 | 0.49% |
| LaSalle Street Capital Management, LLC | 15,897 | $457,000 | 0.45% |
| TFS CAPITAL LLC | 149,318 | $4,294,000 | 0.42% |
| TURNER INVESTMENTS LLC | 71,880 | $2,067,000 | 0.37% |
| NEW AMSTERDAM PARTNERS LLC/NY | 136,116 | $3,915,000 | 0.32% |